Follicular lymphoma trials in Chile

4 of 4 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  Where

  Santiago

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07519772 · EU 2025-523005-15-00
• Phase 2/3Taking people
  A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

  Where

  Concepción, Santiago

  Age

  18 years and over

  People

  960 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07634471 · EU 2025-522777-10-00
• Phase 3Taking people
  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  Where

  Santiago

  Age

  18 years and over

  People

  822 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06091254 · EU 2022-502660-20-00
• Phase 3Not yet taking people in Chile
  A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  Where

  Santiago

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Celgene

  See details and how to joinNCT06911502 · EU 2024-519152-82-00